Perhaps you are a bit tough on OSL re performance of their technology v the SRX spheres. Might they not need to discover this via trials to be conducted?
Actually - I hinted at it on the SRX thread that OSL mode of administration is a huge plus.
Intra-arterial injections, especially in sick patients compared with per cutaneous are more complex, technically difficult, kill more healthy liver, more expensive as they require more imaging, equipment and admission etc etc...
It just shouldnt be me saying that !
It comes back to the old days of Tb testing - and the difference between T spot and QFT. Same issue and even the incredibly conservative CST board could verbalise the issues. Perhaps that is the worry - that the depth of expertise on the OSL board isnt enough to know what is really important to the medical profession ?
OSL Price at posting:
8.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)